Blog - XtremeDev

In:6degree

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015): an ongoing global Parkinson’s disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

March 24, 2021

In:6degree

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015): an ongoing global Parkinson’s disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

March 24, 2021

Observational Spain https://pubmed.ncbi.nlm.nih.gov/31179586/...

In:6degree

Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

March 24, 2021

In:6degree

Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

March 24, 2021

cohort study Germany https://pubmed.ncbi.nlm.nih.gov/30468694/ Objectives:...

In:6degree

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

March 24, 2021

In:6degree

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

March 24, 2021

prospective, longitudinal, single-center cohort study...

In:6degree

The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease

March 24, 2021

In:6degree

The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease

March 24, 2021

longitudinal, observational, cohort...

In:6degree

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology

March 24, 2021

In:6degree

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology

March 24, 2021

prospective, cohort study https://pubmed.ncbi.nlm.nih.gov/32534583/...

In:6degree

Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression

March 24, 2021

In:6degree

Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression

March 24, 2021

prospective, multi-center cohort https://pubmed.ncbi.nlm.nih.gov/28549077/...